Andrew joined Midven in 2004. He is a Director of the Company and Fund Principal of the UK Innovation & Science Seed Fund and the Early Advantage Fund.
After an initial scientific career at Zeneca he went on to roles in research and business development at the medical device company Biocompatibles and then Vice President of Technology for a US start-up in disinfection of medical equipment.
He started his career in VC with the £4m per annum Invention and Innovation seed capital fund at NESTA (the National Endowment for Science Technology and the Arts). He has a degree and a PhD in Chemistry from the University of Oxford.
Andrew combines a strong scientific and technical grounding with a real commercial pragmatism developed from his operational roles.
13:30 - 14:45
Pitching for Success – Afternoon Session
John Henry Brookes Lecture Theatre
Pitching for Success will be to an audience that includes investors, support organisations and individuals.
Each session will include a panel made up of professional funding organisations; including speakers from crowd investment (Peer2Peer, equity, loans), venture capital and public sector funding. Each investor panel speaker will give an overview of what they look for when investing or funding a company followed by Q&A with the audience.
As well as the live pitches and investor panels, the companies from both sessions will be available in the foyer of the John Henry Brookes Lecture Theatre for networking.
Panellists: Tim Colchester – Prodrive, Caroline McGuirk – Anjost Investment, Andrew Muir – MidVen and Rebecca Todd – Longwall Ventures
Pitching Companies: Aquobex Technologies, Cardesium, Cotswold Health Technology, Data Language, Experoment, KYMIRA, Measurable, MEDeus, Oxford Robotics Innovation and Spintex Engineering
Chaired by Eileen Modral – OION
Director, Clusters and Harwell Campus Business Development, UKRI-STFC
Co-founder and Chief Scientific Offer, Oxford PV
Managing Director, Ricardo Energy & Environment
Managing Director, Oxford Instruments NanoScience